Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FREEZE-Path Cohort: Etiology-Phenotype-Outcome Pathway Study on Freezing of Gait (FOG)

NCT07386015 is registered in ClinicalTrials.gov with Tianjin Huanhu Hospital as lead sponsor.

NCT NCT07386015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07386015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FREEZE-Path Cohort: Etiology-Phenotype-Outcome Pathway Study on Freezing of Gait (FOG)
Lead sponsor
Tianjin Huanhu Hospital
Phase
Observational
Overall status
Recruiting
Start date
February 28, 2026
Completion date
November 30, 2030
Enrollment
700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

freezing of gait, idiopathic normal pressure hydrocephalus (inph), parkinson's disease, parkinsonism, vascular parkinsonism